Cyclic aminobenzene derivatives as modulators of blood pressure-1-phosphate receivers; pharmacological components containing these substances; and compounds, allergic reactions, and a for the treatment of eye diseases, inflammation, autoimmune diseases and immunosuppression Dementia.
The present invention relates to novel phenyl bicyclic methyl amine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.COMPUESTOS DERIVADOS DE AMINOMETILFENILO BICICLICO, COMO MODULADORES DEL RECEPTOR DE ESFINGOSINA-1-FOSFATO; COMPOSICION FARMACEUTICA QUE LOS COMPRENDE; Y SU USO PARA TRATAR ENFERMEDADES OCULARES, ENFERMEDADES INFLAMATORIAS, ENFERMEDADES AUTOINMUNES E INMUNOSUPRESION, ATEROSCLEROSIS, ENFERMEDAD DE ALZHEIMER.